- Home
- PAVM vs DRCT Comparison
PAVM vs DRCT Comparison
Compare PAVM & DRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAVM | DRCT |
|---|---|---|
| Founded | 2014 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5M | 8.9M |
| IPO Year | 2016 | 2022 |
Fundamental Metrics
Financial Performance| Metric | PAVM | DRCT |
|---|---|---|
| Price | $8.01 | $3.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $510.00 | $330.00 |
| AVG Volume (30 Days) | 2.9M | ★ 7.4M |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $29,000.00 | ★ $35,369,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $450.56 | $25.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.00 | $1.58 |
| 52 Week High | $28.44 | $80.30 |
Technical Indicators
Market Signals| Indicator | PAVM | DRCT |
|---|---|---|
| Relative Strength Index (RSI) | 57.58 | 69.03 |
| Support Level | $8.53 | $2.82 |
| Resistance Level | $10.55 | $6.04 |
| Average True Range (ATR) | 2.21 | 0.62 |
| MACD | -0.14 | 0.20 |
| Stochastic Oscillator | 9.00 | 50.58 |
Price Performance
Historical ComparisonAbout PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.